522 related articles for article (PubMed ID: 26782918)
1. [Non-melanotic Tumors of the Eyelids Skin and Inner Corner - Basocellular Carcinoma].
Furdová A; Horkovičová K; Babál P; Kobzová D; Ondrušová M
Cesk Slov Oftalmol; 2015; 71(6):293-301. PubMed ID: 26782918
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
4. Malignant eyelid tumours in Taiwan.
Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
[TBL] [Abstract][Full Text] [Related]
5. [Exenteration of the Orbit for Basal Cell Carcinoma].
Furdová A; Horkovičová K; Krčová I; Krásnik V
Cesk Slov Oftalmol; 2015 Aug; 71(4):209-16. PubMed ID: 26395856
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.
Cook BE; Bartley GB
Ophthalmology; 1999 Apr; 106(4):746-50. PubMed ID: 10201597
[TBL] [Abstract][Full Text] [Related]
7. Basal cell carcinoma of the eyelid. Risk of recurrence according to adequacy of surgical margins.
Sigurdsson H; Agnarsson BA
Acta Ophthalmol Scand; 1998 Aug; 76(4):477-80. PubMed ID: 9716337
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of excision of 1750 eyelid and periocular skin basal cell and squamous cell carcinomas by modified en face frozen section margin-controlled technique.
Gayre GS; Hybarger CP; Mannor G; Meecham W; Delfanti JB; Mizono GS; Guerry TL; Chien JS; Sooy CD; Anooshian R; Simonds R; Pietila KA; Smith DW; Dayhoff DA; Engman E; Lacy J
Int Ophthalmol Clin; 2009; 49(4):97-110. PubMed ID: 20348860
[No Abstract] [Full Text] [Related]
9. Minimum histological safety margins in periocular basal cell carcinoma.
Sun MT; Figueira E; Huilgol SC; Selva D
Br J Ophthalmol; 2014 May; 98(5):706. PubMed ID: 24457367
[No Abstract] [Full Text] [Related]
10. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
11. [Descriptive study on basal cell eyelid carcinoma].
Pfeiffer MJ; Pfeiffer N; Valor C
Arch Soc Esp Oftalmol; 2015 Sep; 90(9):426-31. PubMed ID: 25817947
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study and risk factors for recurrence of basal cell carcinoma of the eyelid: results of a Tunisian series and review of the literature].
Knani L; Romdhane O; Ben Rayana N; Mahjoub H; Ben Hadj Hamida F
J Fr Ophtalmol; 2014 Feb; 37(2):107-14. PubMed ID: 24486074
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Metastatic Eyelid Carcinoma.
Bonavolontà P; Dell'Aversana Orabona G; Abbate V; Iaconetta G; Bonavolontà G; Califano L
J Craniofac Surg; 2017 Nov; 28(8):e722-e725. PubMed ID: 28885435
[TBL] [Abstract][Full Text] [Related]
14. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
[TBL] [Abstract][Full Text] [Related]
15. Periocular basal cell carcinoma results and surgical outcome during a 5-year period in a larger Danish population.
Karlsdóttir SB; Johannessen S; Bjerrum NC; Frydkjær-Olsen U; Blindbæk SL; Møller F; Wellejus C
BMC Ophthalmol; 2022 Jun; 22(1):282. PubMed ID: 35761210
[TBL] [Abstract][Full Text] [Related]
16. Clinical-pathological characteristics of patients treated for cancers of the eyelid skin and periocular areas.
Brodowski R; Pakla P; Dymek M; Migut M; Ambicki M; Stopyra W; Ozga D; Lewandowski B
Adv Clin Exp Med; 2019 Mar; 28(3):325-330. PubMed ID: 30277668
[TBL] [Abstract][Full Text] [Related]
17. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
[TBL] [Abstract][Full Text] [Related]
18. 5 years review of periocular basal cell carcinoma and proposed follow-up protocol.
Ho SF; Brown L; Bamford M; Sampath R; Burns J
Eye (Lond); 2013 Jan; 27(1):78-83. PubMed ID: 23154501
[TBL] [Abstract][Full Text] [Related]
19. Clinical, Histopathological and Therapeutical Analysis of Inferior Eyelid Basal Cell Carcinomas.
Totir M; Alexandrescu C; Pirvulescu R; Gradinaru S; Costache M
J Med Life; 2014; 7 Spec No. 4(Spec Iss 4):18-22. PubMed ID: 27057245
[TBL] [Abstract][Full Text] [Related]
20. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
